The Bank of England (BoE) underscored that NIRP is not imminent, but the increase in COVID-19 restrictions and concerns over EU/UK talks may see the GBP/USD pair threaten the 1.25 mark, per Westpac.
Key quotes
“BoE Chief Economist Haldane reiterated, in a firmer tone, Governor Bailey’s statement that UK is not about to embark on NIRP. He stressed that the criteria for implementation have not been met and also stated that the process of ensuring an effective implementation of NIRP, should it be needed, would take months. Haldane is on the hawkish side of the BoE’s MPC, but he clearly intended to reduce market expectations of any early adoption of NIRP and to quell the reactions to the latest MPC minutes.”
“UK’s COVID-19 case counts remain uncomfortably high but have not followed the worst-case acceleration that the Govt. outlined last week. The numbers might even be showing signs of plateauing. Nevertheless, tighter restrictions will remain in place for over 25% of the population with London still on alert. Further restrictions could therefore increase what Haldane referred to as the economic anxiety that might undo the UK’s ‘unexpectedly positive progress’ seen this year.”
“This week’s round of UK-EU negotiations occurred with a less negative tone than had been feared, but any breakthrough remains unlikely and the goal of a deal by mid-October is diminishing. GBP/USD is therefore likely to remain within a 1.25-1.30 range.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD clings to gains near 1.0700, awaits key US data
EUR/USD clings to gains near the 1.0700 level in early Europe on Thursday. Renewed US Dollar weakness offsets the risk-off market environment, supporting the pair ahead of the key US GDP and PCE inflation data.
USD/JPY keeps pushing higher, eyes 156.00 ahead of US GDP data
USD/JPY keeps breaking into its highest chart territory since June of 1990 early Thursday, recapturing 155.50 for the first time in 34 years as the Japanese Yen remains vulnerable, despite looming intervention risks. The focus shifts to Thursday's US GDP report and the BoJ decision on Friday.
Gold price lacks firm intraday direction, holds steady above $2,300 ahead of US data
Gold price remains confined in a narrow band for the second straight day on Thursday. Reduced Fed rate cut bets and a positive risk tone cap the upside for the commodity. Traders now await key US macro data before positioning for the near-term trajectory.
Injective price weakness persists despite over 5.9 million INJ tokens burned
Injective price is trading with a bearish bias, stuck in the lower section of the market range. The bearish outlook abounds despite the network's deflationary efforts to pump the price. Coupled with broader market gloom, INJ token’s doomed days may not be over yet.
Meta takes a guidance slide amidst the battle between yields and earnings
Meta's disappointing outlook cast doubt on whether the market's enthusiasm for artificial intelligence. Investors now brace for significant macroeconomic challenges ahead, particularly with the release of first-quarter gross domestic product (GDP) data on Thursday.